[{"id":"ef9f33ba-d081-412c-af8d-bf768df5b986","acronym":"","url":"https://clinicaltrials.gov/study/NCT02715011","created_at":"2021-01-18T13:16:28.170Z","updated_at":"2024-07-02T16:36:25.083Z","phase":"Phase 1","brief_title":"Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)","source_id_and_acronym":"NCT02715011","lead_sponsor":"Janssen Research \u0026 Development, LLC","biomarkers":" CD123 • IL3RA","pipe":" | ","alterations":" CD123 expression • IL3RA expression","tags":["CD123 • IL3RA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD123 expression • IL3RA expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JNJ-63709178"],"overall_status":"Completed","enrollment":" Enrollment 62","initiation":"Initiation: 06/01/2016","start_date":" 06/01/2016","primary_txt":" Primary completion: 03/26/2021","primary_completion_date":" 03/26/2021","study_txt":" Completion: 03/26/2021","study_completion_date":" 03/26/2021","last_update_posted":"2021-08-31"}]